Wynnefield Capital
http://www.wynnefieldcapital.com/index2.htmWynnefield Capital is a value focused investment firm that specializes in United States small cap situations that have a specific company or industry catalyst. It has an active investment philosophy. However, Wynnefield is not involved in "Green Mail" situations, but instead focuses on collaborative initiatives with management to increase shareholder value.
-
Nevada State Court Orders Omega Protein To Produce NOBO Shareholder List By 3PM PT On Thursday, June 16, 2016
-
Omega Protein (OME) Comments After Court Denies Wynnefield's Motion For Preliminary Injunction
-
Omega Protein Announces Court Denies Wynnefield's Motion For Preliminary Injunction
-
Omega Protein Issues Special Bulletin to Stockholders Regarding Wynnefield Capital's Deficient Proxy Statement
-
Wynnefield Capital Issues Letter To Omega Protein Stockholders
-
Wynnefield Capital Issues Letter To Omega Protein Stockholders
-
Wynnefield Capital Comments On Recent Omega Protein Communications
-
Omega Protein Sends Letter To Stockholders
-
Wynnefield Capital Compelled to Sue Omega Protein For Failure to Make Available Full Set of Books and Records
-
Omega Protein (OME) Comments on Wynnefield Capital Actions; Calls Litigation 'Frivolous'
-
Omega Protein Issues Statement in Response to Frivolous Litigation Tactic by Wynnefield Capital
-
Wynnefield Capital Files Definitive Proxy Statement For Omega Protein Annual Meeting
-
Omega Protein Urges Stockholders To Protect Value Of Their Investment
-
Wynnefield Capital Comments on Omega Protein's First Quarter Financial Results
-
Omega Protein Sends Letter to Stockholders Highlighting Strong Performance Under Current Strategy
-
Wynnefield Capital Demands That Omega Protein Allow Open Q&A On Upcoming First-Quarter Conference Call
-
Wynnefield Calls On Omega To Immediately Set Date For The Annual Meeting
-
Wynnefield Capital Comments on Omega Protein's Fourth Quarter and Full-year Financial Results
-
Omega Protein Issues Statement in Response to Wynnefield Capital's Notice of Director Nominations
-
Pivotal Research Downgrades Omega Protein (OME) to Hold
-
Omega Protein Receives Letter from Shareholder

